ChemImpex Capecitabine; MFCD00930626, 25G

Capecitabine is an innovative chemotherapeutic agent primarily utilized in the treatment of various cancers, including colorectal and breast cancer. As a prodrug, it is metabolized into 5-fluorouracil (5-FU) in the body, allowing for targeted action against cancer cells while minimizing damage to healthy tissues. This selective activation enhances its efficacy and reduces side effects compared to traditional chemotherapy agents. Capecitabines oral administration offers convenience and improved patient compliance, making it a preferred choice in oncology.

In addition to its primary applications, Capecitabine is also being explored in combination therapies, enhancing the effectiveness of other anticancer drugs. Its unique mechanism of action, which involves the inhibition of thymidylate synthase, positions it as a vital component in personalized cancer treatment regimens. Researchers and healthcare professionals appreciate Capecitabine for its ability to provide a more tailored approach to cancer therapy, ultimately leading to better patient outcomes.

Specifications

Safety & Regulations